Client · LDA

SICKLE CELL DISEASE ASSOCIATION OF AMERICA

5 filings 11 bills mentioned 1 registrants 5 quarters ~$100,000 reported

Client ID

56710

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

HR 1796

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

HCR

5

S 735

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

HCR

5

S 721

Sickle Cell Disease Comprehensive Care Act

MMM

5

HR 1

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

INSMMM

4

S 46

Health Care Affordability Act of 2025

INS

3

S 752

Accelerating Kids’ Access to Care Act

MMM

3

HR 5371

Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

INS

3

HR 247

Health Care Affordability Act of 2025

INS

3

HR 1509

Accelerating Kids’ Access to Care Act of 2025

MMM

3

HR 5178

Sickle Cell Disease Comprehensive Care Act

MMM

2

HR 8067

Candis King Hope for Sickle Cell Families Act

BUD

1

Registrants

Lobbying firms that filed on behalf of this client.

ARTEMIS POLICY GROUP LLC 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.